Missing/wrong data?
Log in to edit
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
scientific article
Author/s
author: Henning Beck-Nielsen, Markolf Hanefeld, Michel Komajda, John McMurray, František Saudek, Mona Landin-Olsson, Ramon Gomis i de Barbarà, Paula S Curtis, Philip D Home
Work details
Publication date
June 6, 2009
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.